89,448.39
0.01 BRL
7.96 B BRL
71.13 B BRL
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
ISIN
BRB1SXBDR006
FIGI
BBG00R3WYH83
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.87%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.62%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.38%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
5.15%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
5.09%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.63%
Maturity date
Mar 1, 2028
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
4.61%
Maturity date
Jun 1, 2025
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.55%
Maturity date
Mar 1, 2026
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.54%
Maturity date
Mar 8, 2034
Explore more bonds